Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	2.81	-13.04	-13.58	-13.77	-6.86	-7.1
Depreciation & Amortization	0.04	0.06	0.13	0.23	0.2	0.21
Share-Based Compensation	0.79	0.75	0.46	0.84	0.72	0.85
Other Operating Activities	3.5	2.14	2.56	2.03	-1.38	-2.12
Operating Cash Flow	7.14	-9.56	-10.43	-10.68	-7.32	-8.15
Capital Expenditures	0	0	0.01	-0.06	-0.02	0
Acquisitions	0	0	0	-0.09	-0.22	0
Investing Cash Flow	0	0	0.01	-0.16	-0.24	0
Share Issuance / Repurchase	21.04	6.15	5.36	17.75	4.5	1.78
Debt Issued / Paid	0	0	0	-0.21	0.28	-0
Other Financing Activities	-0.34	-0.19	3.26	0.05	0.22	2.15
Financing Cash Flow	20.7	5.97	8.62	17.58	5	3.92
Exchange Rate Effect	0.01	0.04	-0.09	-0.08	-0.03	0.01
Net Cash Flow	27.85	-3.55	-1.89	6.67	-2.59	-4.23
Free Cash Flow	7.14	-9.56	-10.42	-10.74	-7.34	-8.15
Free Cash Flow Margin	44.61%	-	-	-	-60844.56%	-303.57%
Free Cash Flow Per Share	2.48	-17.76	-128.08	-400.89	-575.28	-922.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).